The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Celgene
A Phase I Trial of ISIS 2503, an Antisense Inhibitor of H-ras in Combination with Gemcitabine in Patients with Advanced Cancer.
 
Volker Kunzmann
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
Uwe Marc Martens
Consulting or Advisory Role - Celgene
 
Hana Alguel
No Relationships to Disclose
 
Jens T. Siveke
Consulting or Advisory Role - Celgene
 
Eray Goekkurt
No Relationships to Disclose
 
Uwe Pelzer
Consulting or Advisory Role - Celgene
 
Gabriele Margareta Siegler
No Relationships to Disclose
 
Elke Hennes
No Relationships to Disclose
 
Dirk Waldschmidt
No Relationships to Disclose
 
Ralf Jakobs
No Relationships to Disclose
 
Peter Ferenczy
Employment - ClinAssess
 
Ralph Keller
No Relationships to Disclose
 
Stefan Hubert Boeck
Honoraria - Celgene
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Frank Kullmann
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
Markus Kapp
No Relationships to Disclose
 
Christoph Thomas Germer
No Relationships to Disclose